All
RSSArticles
-
Combining Large Data Sets Challenges IRBs, Researchers to Ensure Privacy
The problems with HIPAA and current methods of protecting the privacy of individuals in research are being challenged in ways that were not possible in previous decades due to the ease and use of big data. Data scientists and other savvy investigators can combine de-identified data in a way that makes cross-references and re-identification possible.
-
Mobile Technology, Wearables Are Changing Research, Challenging IRBs
Mobile technology and wearable sensors are broadening the limits of research and changing how IRBs view privacy. The voluminous data can point to health strategies previously unimaginable.
-
Big Data Are Changing How IRBs Think About Research
Researchers and sponsors are adapting quickly to virtual technologies and using big data in studies, forcing IRBs and research protection programs to adapt — particularly when it comes to privacy. When IRBs review studies that use big data, they need to be reviewed through the lens of ethical review.
-
Assessing and Treating Exacerbations of Chronic Obstructive Pulmonary Disease
People with chronic obstructive pulmonary disease frequently seek care for acute exacerbations, which are associated with significant morbidity and mortality. Therefore, it is crucial for physicians to understand how to assess and treat these patients appropriately.
-
Uncommon Diagnoses That Cannot Be Missed
Children present to the ED with a variety of issues ranging from benign to life-threatening. The ability to recognize potentially devastating diseases early facilitates care and ensures an optimal outcome for the child.
-
Infectious Disease Alert Updates
Things Do Not Always Go Better with Cola; ‘Hygiene Theater’; Geodynamics of COVID-19 in Brazil
-
Respiratory Syncytial Virus — Not Just a Disease of Children
Respiratory syncytial virus is a significant cause of morbidity and mortality in the elderly.
-
A Novel Rifabutin-Containing Combination Regimen Is Effective for Eradicating H. pylori Infection
A Phase III, randomized, controlled trial found a significantly higher eradication rate for H. pylori with a 14-day regimen of rifabutin, amoxicillin, and omeprazole compared to 14 days of amoxicillin and omeprazole.
-
Respiratory Syncytial Virus — Effective Prevention Still Needed
Prevention of respiratory syncytial virus infection is needed but challenging. New studies show some favorable effectiveness on infant outcomes with both vaccination of healthy pregnant women and passive single-dose immunization of prematurely born babies.
-
Repeat Infections with Endemic Coronaviruses and Possible Implications for COVID-19
Repeat infection with endemic seasonal coronavirus occurs commonly and raises concerns about immunity to SARS-CoV-2 as well as about the efficacy of vaccines in the protection against infection due to this virus.